Aims: To examine the expression of EphA2 and EphrinA-1 in vulvar squamous cell carcinomas and investigate their prognostic relevance.
Methods: Tumors from 224 patients with vulvar squamous cell carcinomas were investigated for expression of EphA2 and EphrinA-1 using single and double immunostaining methods.
Results: High expression (strong/moderate staining intensity) of EphA2 and EphrinA-1 was observed in 114 (51%) and 126 (56%) vulvar carcinomas, respectively. In the three cases tested using double immunostaining method colocalization of EphA2 and EphrinA-1 proteins were identified in the same neoplastic cells. High EphA2 expression was significantly correlated to high expression of EphrinA-1 (P < 0.01) and cyclin A (P < 0.01), large tumor size (P = 0.03), deep invasion (P < 0.01) and higher FIGO stage (P = 0.05). A correlation between high EphrinA-1 expression and high levels of cyclin A (P < 0.01) and p21 (P < 0.01), deep invasion (P < 0.01) and higher FIGO stage (P = 0.01) was also seen. In univariate analysis, high expression of EphrinA-1 was associated with poor survival (P = 0.03). However, in the multivariate analysis neither EphrinA-1 nor EphA2 were significantly correlated to survival.
Conclusions: EphA2 and EphrinA-1 are overexpressed in 51% and 56% of the vulvar squamous cell carcinomas, respectively, and high levels of EphA2 and EphrinA-1 proteins are associated with deep tumor invasion and high FIGO stage. However, EphA2 and EphrinA-1 are not independently associated with clinical outcome in vulvar carcinomas.
- vulvar cancer
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.